Arca Biopharma | ABIO - Market Capitalization


Arca Biopharma reported $1.34B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alterity Therapeutics Limited AUD 39M 17M Sep/2026
Amgen USD 195.44B 5.55B Jun/2026
Arca Biopharma USD 2.43B 963M Mar/2026
Biogen USD 31.9B 5B Jun/2026
Brainstorm Cell Therapeutics USD 11M 3M Mar/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Capricor Therapeutics USD 1.66B 1.33B Dec/2025
Cipla INR 1.18T 194.93B Jun/2026
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
Compugen USD 620.29M 475.62M Mar/2026
CSL USD 55.89B 20.42B Dec/2025
Cytokinetics USD 11.55B 3.36B Jun/2026
Gilead Sciences USD 156.86B 16.13B Jun/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
Laboratory Of America USD 22.96B 1.03B Jun/2026
Otsuka Holdings JPY 5.87T 111.31B Jun/2026
Pfizer USD 138.44B 15.37B Jun/2026
United Therapeutics USD 23B 2.19B Jun/2026